Wallace L. Akerley, MD, discusses using MET as a biomarker in lung cancer.
Wallace L. Akerley, MD
Advertisement
Articles by Wallace L. Akerley, MD
Advertisement
Latest Updated Articles
Dr. Akerley on MET Biomarker in Lung CancerPublished: October 23rd 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis
5